Cochrane Abstracts
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies New
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436275/all/First���line_tandem_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma_a_systematic_review_of_controlled_studies_New. Accessed 24 May 2022.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436275/all/First���line_tandem_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma_a_systematic_review_of_controlled_studies_New. Accessed May 24, 2022.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436275/all/First���line_tandem_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma_a_systematic_review_of_controlled_studies_New
First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies New [Internet]. In: Cochrane Abstracts. [cited 2022 May 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436275/all/First���line_tandem_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma_a_systematic_review_of_controlled_studies_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies New
ID - 436275
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436275/all/First���line_tandem_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high���dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma_a_systematic_review_of_controlled_studies_New
DB - Evidence Central
DP - Unbound Medicine
ER -
